MK 4575 for MSI tumors of Lynch syndrome, now under clinical study - TopicsExpress



          

MK 4575 for MSI tumors of Lynch syndrome, now under clinical study at Johns Hopkins. Immune therapy may be the treatment we have been waiting for...if anyone has a late staged family member who is not responding to treatment, contact Dr. Le Dung at Johns Hopkins to learn more abt the Lynch Syndrome PD1 study ongoing with Merck. Opening at various locations across the U.S. clinicaltrials.gov/show/NCT01876511
Posted on: Wed, 30 Jul 2014 00:31:04 +0000

Trending Topics



Recently Viewed Topics




© 2015